NCT01995084View on ClinicalTrials.gov

In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Pancreatic CancerEsophageal CancerRectal Cancer
Interventions
DRUG

[F-18]HX4

400 MBq \[F-18\]HX4, is administered in a single intravenous bolus injection, followed by a saline flush.

Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT01995084 - In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study | Biotech Hunter | Biotech Hunter